Ilaina Leavitt
About Ilaina Leavitt
Ilaina Leavitt is the Senior Director of Hematology Customer & Market Insights at Bristol Myers Squibb in Princeton, New Jersey, with extensive experience in market research and customer insights across various therapeutic areas.
Company
Ilaina Leavitt is currently serving as the Senior Director, Hematology Customer & Market Insights at Bristol Myers Squibb. Headquartered in Princeton, New Jersey, the company is renowned for its advancements in medical research, with a specific focus on hematology. Her role involves providing valuable customer insights to guide business strategies within the hematology sector.
Title
Ilaina Leavitt holds the title of Senior Director, Hematology Customer & Market Insights at Bristol Myers Squibb. Her responsibilities include leveraging customer and market data to inform strategic brand decisions and driving pivotal business decisions within the hematology arena.
Education and Expertise
Ilaina Leavitt has a strong academic background, having earned an MBA in Strategic Management from Rutgers University from 1997 to 2000. Prior to that, she completed her BA in Psychology and Spanish at Lafayette College, where she studied from 1990 to 1994. Her expertise lies in integrating secondary data to synthesize customer insights, which she has applied across various therapeutic areas and product development stages.
Background
Ilaina Leavitt has an extensive work history at Bristol Myers Squibb, beginning as a Manager of Market Research in 2004 and progressing through various roles. She has held numerous positions, including Director, Global Cardiovascular Customer Insights, and Director, Early Oncology Customer & Market Insights. Additionally, she has experience in market research and human resources at Philips Lighting Company and Hanover Direct.
Achievements
Throughout her career at Bristol Myers Squibb, Ilaina Leavitt has led teams responsible for driving business decisions based on customer insights. She has worked across multiple therapeutic areas, including Myeloma, Myeloid, and Leukemia & Lymphoma. Her role has involved strong matrix collaboration both in the US and globally, ensuring the integration of customer insights into strategic brand decision-making.